How Many Types of Arthritis Are There? 4 Categories

Arthritis covers over 100 conditions, but they fall into four main categories. Learn which type affects you and why the category shapes your treatment.

More than 100 distinct conditions fall under the umbrella term “arthritis,” but rheumatologists generally sort them into four broad categories: degenerative, inflammatory/autoimmune, metabolic/crystalline, and infectious. Each category has a different underlying cause, affects the joints through a different mechanism, and calls for a different treatment strategy. The number 100-plus can sound overwhelming, but understanding these four groupings gives you a practical framework for making sense of almost any arthritis diagnosis you or someone you know might encounter.

Degenerative Arthritis

Osteoarthritis is the most familiar type and the sole major member of the degenerative category. It is also the most common form of arthritis worldwide, with knee osteoarthritis alone affecting thousands per hundred thousand people globally and its prevalence rising steadily since 1990. The disease has deep evolutionary roots: paleopathological studies have found osteoarthritis in human and hominid remains going all the way back to the Paleolithic era.

At its core, osteoarthritis involves the gradual breakdown of articular cartilage, the smooth tissue capping the ends of bones inside a joint. But the damage doesn’t stop at cartilage. Abnormal mechanical stress causes microfractures in the subchondral bone just beneath the cartilage surface, triggering a remodeling cycle that eventually produces bone thickening and the bony spurs visible on X-rays. As the cartilage cracks and thins, synovial fluid seeps into the bone, carrying inflammatory molecules that accelerate the damage further. New blood vessels and nerve fibers grow into regions that were previously insulated from them, which is one reason osteoarthritis can become progressively more painful over time.

For decades, excess body weight was assumed to cause osteoarthritis purely through mechanical overload on weight-bearing joints. That explanation is too simple. Fat tissue itself releases inflammatory signaling molecules, and factors like insulin resistance and abnormal fat metabolism play independent roles in driving cartilage breakdown, even in non-weight-bearing joints like the hands. Obesity also appears to alter the behavior of cartilage cells directly, with pressure-sensing receptors on those cells triggering damaging enzyme cascades.

Inflammatory and Autoimmune Arthritis

The second category includes conditions where the immune system attacks the joints. Rheumatoid arthritis is the prototype. In rheumatoid arthritis, persistent inflammation of the synovial membrane, the thin lining inside a joint capsule, generates an aggressive tissue called pannus that invades and destroys cartilage and the underlying bone. Unlike osteoarthritis, which typically worsens with use and improves with rest, rheumatoid arthritis often produces morning stiffness lasting an hour or more and can flare regardless of activity level.

Rheumatoid arthritis disproportionately affects women and has been rising globally, with incidence increases most pronounced in certain low- and middle-income regions over the past three decades. Researchers are increasingly linking these trends to environmental and lifestyle factors. Changes in the composition of gut bacteria have been found in people at risk for rheumatoid arthritis even before joint symptoms appear, suggesting that what happens in the intestines can set the stage for immune dysfunction in the joints.

Psoriatic arthritis and ankylosing spondylitis also belong in this category. Both are linked to a genetic marker called HLA-B27 and fall under the broader umbrella of spondyloarthritis. Psoriatic arthritis occurs in a substantial fraction of people with psoriasis and can affect fingers and toes in distinctive ways, including sausage-like swelling of entire digits. Ankylosing spondylitis targets the spine and sacroiliac joints, sometimes fusing vertebrae together over years. Research using genetic analysis has suggested that certain gut bacteria may drive the inflammatory pathway behind ankylosing spondylitis, specifically by raising levels of an immune signaling molecule called IL-7 that activates a chain of events promoting spinal inflammation.

Metabolic and Crystalline Arthritis

Gout is the marquee condition in this category. It happens when uric acid, a normal waste product of metabolism, builds up in the blood and forms needle-shaped monosodium urate crystals that deposit in joints and surrounding tissues. Those crystals activate a potent inflammatory alarm system inside cells, leading to sudden, excruciating attacks of joint pain, redness, and swelling. The big toe is the classic site, but gout can strike ankles, knees, wrists, and fingers too.

Standard treatment for gout focuses on lowering uric acid levels with drugs like allopurinol. The problem is that uric acid control alone doesn’t fully shut down the inflammatory cascade that damages the joint during flares. For people with severe gout who don’t respond to conventional drugs, a biologic therapy called pegloticase can bring uric acid under control: in pivotal trials, about 42% of patients receiving it every two weeks maintained target uric acid levels through six months of treatment.

The other major crystalline arthritis is calcium pyrophosphate deposition disease, sometimes called pseudogout because it mimics gout’s sudden flares. Here the culprit crystals are made of calcium pyrophosphate rather than urate, and they tend to deposit in cartilage and soft tissues around joints, causing both acute attacks and chronic joint damage. Pseudogout is particularly common in older adults and frequently targets the knee and wrist. To complicate matters, some patients harbor more than one type of crystal: early research found that deposits with properties consistent with a different calcium phosphate compound could produce similar symptoms, meaning crystal arthritis isn’t always a one-crystal story.

Infectious Arthritis

When bacteria, viruses, or fungi invade a joint, the result is infectious or septic arthritis. Staphylococcus aureus is the most common bacterial cause, and it can destroy a joint with alarming speed. Research in animal and lab models shows that staph toxins kill cartilage cells directly, beginning at the surface and burrowing deeper within hours. The bacteria also trigger cartilage cells to release their own destructive enzymes, compounding the damage. Most of the cartilage destruction is caused by the toxin itself rather than by the body’s immune response, though the immune system adds a smaller secondary toll. Septic arthritis is a medical emergency; delay in drainage and antibiotics can mean permanent joint damage or worse.

Reactive arthritis is a related but distinct condition in this category. It develops after an infection somewhere else in the body, usually the gut or the urinary tract, and typically shows up as an asymmetric swelling in one or a few lower-limb joints. Patients may also develop eye inflammation, skin lesions on the soles of the feet, and urethritis. Unlike true septic arthritis, you won’t find live organisms in the affected joint. The inflammation is driven by the immune system’s reaction to residual bacterial fragments rather than by active infection in the joint itself.

Conditions That Cross Category Lines

Real-world arthritis doesn’t always fit neatly into one of the four boxes. Some conditions straddle categories or are grouped separately depending on who is doing the classifying.

Post-traumatic osteoarthritis develops in a joint after a significant injury such as an ACL tear, a meniscus injury, or a fracture extending into the joint surface. It resembles ordinary osteoarthritis once it’s established, but it arises from a distinct triggering event, and the initial damage involves a burst of cell death, mitochondrial dysfunction, and inflammatory signaling that seeds degeneration years before typical wear-and-tear arthritis would appear. Young athletes who suffer major knee injuries, for example, often develop knee arthritis decades earlier than their uninjured peers.

Lupus arthritis is another example. Systemic lupus erythematosus is an autoimmune disease that can attack almost any organ, and joint involvement is one of its most common features, typically affecting the hands and knees. Lupus-related arthritis can be sorted into at least three subtypes with different imaging findings and blood markers. Some classifications lump it under inflammatory/autoimmune, others consider it connective tissue disease arthritis. For the patient, the distinction matters because lupus arthritis treatment overlaps with but isn’t identical to rheumatoid arthritis treatment.

Juvenile idiopathic arthritis presents yet another complication. It is actually a family of seven mutually exclusive subtypes defined by the International League Against Rheumatism, and its underlying mechanisms involve both autoimmune and autoinflammatory pathways. Some subtypes closely resemble adult rheumatoid arthritis or ankylosing spondylitis, while others, like systemic-onset juvenile idiopathic arthritis, behave more like autoinflammatory conditions with high fevers and rashes in addition to joint swelling. Grouping all seven subtypes under one “pediatric” heading obscures the fact that they span multiple categories from the adult classification system.

Telling Them Apart

Accurate diagnosis matters because treatments that help one category can be useless or harmful for another. Immunosuppressive drugs that control rheumatoid arthritis, for instance, could be disastrous in septic arthritis, where you need the immune system firing on all cylinders to clear an infection.

Blood tests are one of the first tools doctors reach for. Anti-CCP antibodies are particularly useful for rheumatoid arthritis: in studies comparing patients with joint erosions to those without, anti-CCP antibodies had the highest predictive value of any single marker tested, outperforming rheumatoid factor and inflammatory markers like CRP and ESR. Uric acid levels help confirm gout, though they can be deceptively normal during an acute attack. HLA-B27 testing supports a spondyloarthritis diagnosis but isn’t definitive on its own.

Joint fluid analysis remains the gold standard for some diagnoses. A sample drawn from a swollen joint can be examined under a polarizing microscope to identify urate or calcium pyrophosphate crystals, which immediately narrows the diagnosis to the metabolic/crystalline category. The same fluid can be stained and cultured for bacteria. Careful microscopic examination of joint fluid preparations can identify the offending organism in roughly 87% of cases of infectious arthritis. This is why rheumatologists emphasize tapping an acutely swollen joint when the cause isn’t obvious: the fluid itself is often more informative than imaging or blood work.

Why the Number “Over 100” Is Both Real and Misleading

You’ll often see claims that there are “more than 100 types of arthritis.” That figure comes from counting every specific diagnosis and subtype within each of the four categories. Osteoarthritis alone can be subdivided by joint site (knee, hip, hand, spine), by cause (primary vs. post-traumatic), or by imaging pattern. Rheumatoid arthritis can be seropositive or seronegative. Juvenile idiopathic arthritis splits into seven subtypes. Crystalline arthritis includes gout, pseudogout, and less common crystal diseases. Infectious arthritis covers bacterial, viral, fungal, and mycobacterial causes. Add in rare conditions like palindromic rheumatism, relapsing polychondritis, and arthritis associated with inflammatory bowel disease, and the list grows quickly.

But the 100-plus figure can be misleading because it implies that these are all equally common or equally distinct. In practice, a handful of diagnoses account for the vast majority of cases. Osteoarthritis alone dwarfs everything else in prevalence. Rheumatoid arthritis, gout, and psoriatic arthritis make up most of the remaining burden. Many of the other “types” are rare conditions you’d see in a specialized referral center, not in a primary care office. Knowing the four categories gives you a clearer mental model than trying to memorize a hundred names.

Diet, Exercise, and Inflammation Across Categories

Lifestyle interventions crop up in the management of nearly every form of arthritis, but the evidence is strongest for osteoarthritis. A meta-analysis of dietary interventions in people with osteoarthritis found that reduced-energy diets produced meaningful improvements in pain and physical function, while the Mediterranean diet alone did not reach statistical significance for those outcomes. The explanation is probably straightforward: losing weight reduces both the mechanical load on joints and the low-grade inflammation driven by excess fat tissue. A separate evidence synthesis argued that a plant-based diet combined with regular physical activity can reduce the chronic low-grade inflammation underlying osteoarthritis, and that treating these lifestyle factors as first-line interventions rather than afterthoughts has the potential to slow disease progression and reduce the need for medications and surgery.

For gout, dietary changes center on limiting foods high in purines, the compounds the body converts to uric acid. Red meat, organ meats, shellfish, and beer are the usual suspects. Reducing purine intake won’t cure gout on its own, and most people with persistently elevated uric acid will still need medication, but diet can reduce flare frequency.

In inflammatory/autoimmune arthritis, the picture is murkier. Exercise is broadly beneficial for joint function and fatigue, and some anti-inflammatory dietary patterns show promise, but the evidence doesn’t support replacing disease-modifying drugs with lifestyle changes. The stakes are higher here: unchecked rheumatoid arthritis causes irreversible erosion within months to years, and lifestyle interventions simply can’t suppress that process fast enough on their own.

The Gut-Joint Connection

One of the more surprising areas of recent arthritis research is the growing evidence that the gut microbiome plays a role in joint inflammation. In rheumatoid arthritis, alterations in the bacterial populations of the intestines have been documented not only in people with established disease but also in individuals who are at risk but haven’t yet developed symptoms. The theory is that a disrupted microbial community in the gut may allow immune cells to become primed in a way that eventually targets joint tissue.

In ankylosing spondylitis, the connection may be even more direct. Genetic analysis has implicated specific bacterial groups, particularly Bacillales, in raising levels of an immune-signaling molecule that activates inflammatory pathways central to the spinal inflammation characteristic of the disease. This research is still in its early stages, and no microbiome-targeted therapy for arthritis has yet proven itself in large clinical trials. But it does help explain why inflammatory arthritis is a systemic disease rather than purely a joint problem, and why future treatments may look very different from the drugs available today.